-
Novo Nordisk A/S (NVO $50.30)
- $50.30 P/E (TTM): 16.88X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Eli Lilly and Company (LLY $1,003.46)
- $1,003.46 P/E (TTM): 50.74X Cap: $948.65B
- View LLY Profile
- View Questions on LLY
-
Novo Nordisk A/S (NVO $50.30)
- $50.30 P/E (TTM): 16.88X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Q: With the weight loss drugs now moving into pills, it seems like they will be even more popular. Do you have any suggestions of specific companies whose stock will benefit from this going forward. Or has this horse already left the barn.
-
Eli Lilly and Company (LLY $1,003.46)
- $1,003.46 P/E (TTM): 50.74X Cap: $948.65B
- View LLY Profile
- View Questions on LLY
-
Novo Nordisk A/S (NVO $50.30)
- $50.30 P/E (TTM): 16.88X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Q: Do you still prefer LLY over NVO given the latest developments at NVO (pill)?
-
Eli Lilly and Company (LLY $1,003.46)
- $1,003.46 P/E (TTM): 50.74X Cap: $948.65B
- View LLY Profile
- View Questions on LLY
-
Novo Nordisk A/S (NVO $50.30)
- $50.30 P/E (TTM): 16.88X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Q: What's the best way to play the GLP-1/Semaglutide bandwagon now that the WHO is encouraging its use as a way to better health through weight loss?
Insiders
Share Information
SEC Filings
News and Media